Weiyi Peng to Mice
This is a "connection" page, showing publications Weiyi Peng has written about Mice.
Connection Strength
1.032
-
MTA-cooperative PRMT5 inhibitors enhance T cell-mediated antitumor activity in MTAP-loss tumors. J Immunother Cancer. 2024 Sep 23; 12(9).
Score: 0.180
-
Faslpr gene dosage tunes the extent of lymphoproliferation and T cell differentiation in lupus. Clin Immunol. 2024 01; 258:109874.
Score: 0.170
-
Inhibiting Type I Arginine Methyltransferase Activity Promotes T Cell-Mediated Antitumor Immune Responses. Cancer Immunol Res. 2022 Apr 01; 10(4):420-436.
Score: 0.151
-
Integrating genome-wide CRISPR immune screen with multi-omic clinical data reveals distinct classes of tumor intrinsic immune regulators. J Immunother Cancer. 2021 02; 9(2).
Score: 0.140
-
Development of a RIPK1 degrader to enhance antitumor immunity. Nat Commun. 2024 Dec 16; 15(1):10683.
Score: 0.046
-
UBA1 inhibition sensitizes cancer cells to PARP inhibitors. Cell Rep Med. 2024 Dec 17; 5(12):101834.
Score: 0.046
-
IRE1a silences dsRNA to prevent taxane-induced pyroptosis in triple-negative breast cancer. Cell. 2024 Dec 12; 187(25):7248-7266.e34.
Score: 0.045
-
Lymphocyte-Activation Gene 3 Facilitates Pathological Tau Neuron-to-Neuron Transmission. Adv Sci (Weinh). 2024 Apr; 11(16):e2303775.
Score: 0.043
-
Peripheral MC1R Activation Modulates Immune Responses and is Neuroprotective in a Mouse Model of Parkinson's Disease. J Neuroimmune Pharmacol. 2023 Dec; 18(4):704-717.
Score: 0.043
-
Clinically translatable cytokine delivery platform for eradication of intraperitoneal tumors. Sci Adv. 2022 Mar 04; 8(9):eabm1032.
Score: 0.038
-
The Glutaminase Inhibitor CB-839 (Telaglenastat) Enhances the Antimelanoma Activity of T-Cell-Mediated Immunotherapies. Mol Cancer Ther. 2021 Mar; 20(3):500-511.
Score: 0.035
-
Aurora kinase inhibition sensitizes melanoma cells to T-cell-mediated cytotoxicity. Cancer Immunol Immunother. 2021 Apr; 70(4):1101-1113.
Score: 0.034
-
A Novel Mitochondrial Inhibitor Blocks MAPK Pathway and Overcomes MAPK Inhibitor Resistance in Melanoma. Clin Cancer Res. 2019 Nov 01; 25(21):6429-6442.
Score: 0.032
-
CXCR5+CD8+ T cells are a distinct functional subset with an antitumor activity. Leukemia. 2019 Nov; 33(11):2640-2653.
Score: 0.031